MEDI-573
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MEDI-573, covering 2014-12-11 to 2019-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors [Phase 1]